Retractable Technologies, Inc. (RVP)
NYSEAMERICAN: RVP · Real-Time Price · USD
0.6646
+0.0042 (0.64%)
Jul 21, 2025, 4:00 PM - Market closed

Company Description

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.

The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network.

Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Retractable Technologies, Inc.
Retractable Technologies logo
CountryUnited States
Founded1994
IPO DateMay 4, 2001
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees227
CEOThomas Shaw

Contact Details

Address:
511 Lobo Lane
Little Elm, Texas 75068-5295
United States
Phone972 294 1010
Websiteretractable.com

Stock Details

Ticker SymbolRVP
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000946563
CUSIP Number76129W105
ISIN NumberUS76129W1053
Employer ID75-2599762
SIC Code3841

Key Executives

NamePosition
Thomas J. ShawFounder, Chairman, President and Chief Executive Officer
John W. Fort IIIVice President, Chief Financial Officer, Principal Accounting Officer,Treasurer and Director
Lawrence G. SalernoDirector of Operations
Michele M. Larios Esq.Vice President, General Counsel and Secretary
Russell B. KuhlmanVice President of Sales Development

Latest SEC Filings

DateTypeTitle
Jun 30, 20258-KCurrent Report
Jun 6, 20258-KCurrent Report
May 21, 20258-KCurrent Report
May 15, 20258-KCurrent Report
May 15, 202510-QQuarterly Report
Apr 11, 20258-KCurrent Report
Mar 28, 20258-KCurrent Report
Mar 28, 202510-KAnnual Report
Mar 28, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 28, 2025DEF 14AOther definitive proxy statements